Health Nov 30 FDA panel review final hurdle for Merck’s COVID-19 pill U.S. health advisers are reviewing Merck's closely watched COVID-19 pill, which could become the first easy-to-use drug for American patients.
Health Nov 19 WATCH: CDC advisory panel votes approves COVID-19 booster shots for all adults An influential U.S. advisory panel will discuss expanding eligibility for COVID-19 vaccine booster shots to all adults Friday, a move that could make the shots available as early as this weekend.
Health Nov 19 FDA expands COVID boosters to all adults, final hurdle ahead If the Centers for Disease Control and Prevention agrees, tens of millions more Americans could have three doses of protection ahead of the new year. Anyone who got the one-dose Johnson & Johnson vaccine can already get a booster.
Health Nov 16 Pfizer asks U.S. regulators to approve promising COVID pill Pfizer is submitting its experimental pill for COVID-19 for U.S. authorization, setting the stage for a likely launch of the promising therapy in coming weeks.
Politics Nov 12 Biden picks former FDA chief Califf to again lead the agency Califf served as FDA commissioner for the last 11 months of President Barack Obama’s second term.
Health Nov 05 Pfizer says COVID-19 pill cut hospital, death risk by 90 percent Since the beginning of the pandemic last year, researchers worldwide have been racing to find a pill to treat COVID-19 that can be taken at home to ease symptoms, speed recovery and keep people out of the hospital.
Health Nov 04 U.K. authorizes Merck antiviral pill, 1st shown to treat COVID Britain has granted a conditional authorization to Merck's coronavirus antiviral. It's the first pill shown to successfully treat COVID-19.
Health Oct 29 WATCH: FDA paves way for Pfizer COVID-19 vaccinations in young kids Next week, advisers to the CDC will discuss which youngsters should get vaccinated. In the meantime, Pfizer plans to begin shipping millions of vials of the new doses to vaccination sites.
Health Oct 26 FDA panel backs Pfizer’s low-dose COVID-19 vaccine for kids The vote Tuesday by the Food and Drug Administration panel moves the nation closer to vaccinating children ages 5 to 11. The FDA isn't bound by the recommendation and is expected to make its own decision within days.
Nation Oct 26 WATCH: FDA advisers endorse COVID-19 vaccines for kids ages 5 to 11 The U.S. moved a step closer to expanding COVID-19 vaccinations for millions more children as a panel of government advisers on Tuesday endorsed kid-size doses of Pfizer's shots for 5- to 11-year-olds.